SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-22-024223
Filing Date
2022-05-05
Accepted
2022-05-05 16:01:16
Documents
2
Group Members
BOHLINI INVEST GMBH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea159458-13dvonbohlen_cure.htm SC 13D 109256
2 JOINT FILING AGREEMENT ea159458ex99-2_cure.htm EX-99.2 5507
  Complete submission text file 0001213900-22-024223.txt   116140
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Subject) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91630 | Film No.: 22896015
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUENHELMER LANDSTRASSE 4 HELDELBERG 2M 69120
Business Address
von Bohlen und Halback Friedrich (Filed by) CIK: 0001918389 (see all company filings)

Type: SC 13D